Screening for Liver Cancer: The Rush to Judgment

Annals of Internal Medicine

Volumn 156, Issue 5, 2012, Pages 387-389

  Lederle, Frank A ^a   Pocha, Christine ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN;

ARTICLE; CANCER SCREENING; CHINA; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PATIENT CARE; PRIORITY JOURNAL;

EID: 84857735439     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-5-201203060-00012     Document Type: Article

References (22)

1. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepa-tology. 2005;42:1208-36. [PMID: 16250051]
2. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53: 1020-2. [PMID: 21374666]
3. Stroffolini T, Sagnelli E, Almasio P, Ferrigno L, Craxì A, Mele A; Italian Hospitals Collaborating Groups. Characteristics of liver cirrhosis in Italy: results from a multicenter national study. Dig Liver Dis. 2004;36:56-60. [PMID: 14971816]
4. Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. Vital Health Stat 10. 2010:1-207. [PMID: 21905346]
5. Wong CR, Garcia RT, Trinh HN, Lam KD, Ha NB, Nguyen HA, et al. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci. 2009;54:2712-21. [PMID: 19876735]
6. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010;52:132-41. [PMID: 20578139]
7. Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154:85-93. [PMID: 21242365]
8. Sharma P, Saini SD, Kuhn LB, Rubenstein JH, Pardi DS, Marrero JA, et al. Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci. 2011;56:569-77. [PMID: 20978844]
9. Chen JG, Parkin DM, Chen QG, Lu JH, Shen QJ, Zhang BC, et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen. 2003;10:204-9. [PMID: 14738659]
10. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417-22. [PMID: 15042359]
11. Isaakidis P, Ioannidis JP. Evaluation of cluster randomized controlled trials in sub-Saharan Africa. Am J Epidemiol. 2003;158:921-6. [PMID: 14585770]
12. Senn S. Controversies concerning randomization and additivity in clinical trials. Stat Med. 2004;23:3729-53. [PMID: 15580598]
13. Kerry SM, Bland JM. Analysis of a trial randomised in clusters. BMJ. 1998; 316:54. [PMID: 9451271]
14. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology. 2003; 226:533-42. [PMID: 12563151]
15. Lauer MS. Pseudodisease, the next great epidemic in coronary atherosclerosis?: comment on "Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population". Arch Intern Med. 2011;171:1268-9.[PMID: 21606092]
16. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, et al; HALT-C Trial Group. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010;8:877-83. [PMID: 20362695]
17. Davila JA, El-Serag HB. Surveillance for hepatocellular carcinoma [Author Reply]. Ann Intern Med. 2011;155:275.
18. Trevisani F, De NS, Rapaccini G, Farinati F, Benvegnu L, Zoli M, et al; Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97:734-44. [PMID: 11922571]
19. Poustchi H, Farrell GC, Strasser SI, Lee AU, McCaughan GW, George J. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology. 2011;54:1998-2004. [PMID: 21800340]
20. Stravitz RT, Heuman DM, Chand N, Sterling RK, Shiffman ML, Luketic VA, et al. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med. 2008;121:119-26. [PMID: 18261500]
21. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med. 2002;346:529-31. [PMID: 11844859]
22. National Cancer Institute. Liver (Hepatocellular) Cancer Screening (PDQ). Bethesda, MD: National Cancer Institute; 2011. Accessed at www.cancer.gov /cancertopics/pdq/screening/hepatocellular/HealthProfessional on 17 January 2012.